Literature DB >> 16408165

[Drug-induced pulmonary damage].

K-M Müller1, B M Einsfelder.   

Abstract

The frequency of drug-induced damage to the lung in inpatients is estimated to be about 10%. Pathoanatomically, varying damage patterns result, ranging from acute pulmonary edema via inflammatory reactions to pulmonary fibrosis. The ATS/ERS 2001 classification, which is based on the suggestions made by Liebow 1969, is an accepted system for classifying findings according to recurring patterns. Generally, there are no specific morphological findings which allow safe conclusions on possible administered drugs. Clinical information is mandatory. Differentiation from pulmonary alterations due to the underlying disease is often difficult. In daily routine diagnostics, it is important to consider iatrogenic causal factors in cases of "undetermined pulmonary disease".

Entities:  

Mesh:

Year:  2006        PMID: 16408165     DOI: 10.1007/s00292-005-0812-z

Source DB:  PubMed          Journal:  Pathologe        ISSN: 0172-8113            Impact factor:   1.011


  10 in total

Review 1.  American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias. This joint statement of the American Thoracic Society (ATS), and the European Respiratory Society (ERS) was adopted by the ATS board of directors, June 2001 and by the ERS Executive Committee, June 2001.

Authors: 
Journal:  Am J Respir Crit Care Med       Date:  2002-01-15       Impact factor: 21.405

Review 2.  Drug-induced lung disease.

Authors:  M Ozkan; R A Dweik; M Ahmad
Journal:  Cleve Clin J Med       Date:  2001-09       Impact factor: 2.321

Review 3.  Drug-induced pulmonary disease. An update.

Authors:  E C Rosenow; J L Myers; S J Swensen; R J Pisani
Journal:  Chest       Date:  1992-07       Impact factor: 9.410

4.  [Adverse drugs reactions: diagnosis and assessment].

Authors:  P A Thürmann
Journal:  Pathologe       Date:  2006-02       Impact factor: 1.011

5.  [Idiopathic interstitial pneumonias: pathomechanisms and therapeutic options].

Authors:  P Markart; L Hundack; A Ghofrani; F Grimminger; W Seeger; A Günther
Journal:  Pneumologie       Date:  2005-08

6.  [Proliferation kinetics of bronchioloalveolar tumorlets].

Authors:  A Theile; K M Müller
Journal:  Pathologe       Date:  1996-03       Impact factor: 1.011

7.  Drugs that may injure the respiratory system.

Authors:  P Foucher; M Biour; J P Blayac; P Godard; C Sgro; M Kuhn; J M Vergnon; D Vervloet; P Pfitzenmeyer; M Ollagnier; C Mayaud; P Camus
Journal:  Eur Respir J       Date:  1997-02       Impact factor: 16.671

8.  Fatal drug reactions among medical inpatients.

Authors:  S Shapiro; D Slone; G P Lewis; H Jick
Journal:  JAMA       Date:  1971-04-19       Impact factor: 56.272

9.  Pulmonary complications associated with illicit drug use. An update.

Authors:  A E O'Donnell; J Selig; M Aravamuthan; M S Richardson
Journal:  Chest       Date:  1995-08       Impact factor: 9.410

Review 10.  Pulmonary disease due to antirheumatic agents.

Authors:  R J Zitnik; J A Cooper
Journal:  Clin Chest Med       Date:  1990-03       Impact factor: 2.878

  10 in total
  2 in total

1.  [Drug-induced pulmonary diseases].

Authors:  D Ukena
Journal:  Pneumologe (Berl)       Date:  2007-04-26

2.  [Drug-induced disorders of the lung parenchyma].

Authors:  J Schreiber
Journal:  Pneumologe (Berl)       Date:  2009-08-01
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.